We conclude that the IL-7/STAT5 pathway is not mutated or constitutively activated in the Zeb2-overexpressing T-ALL cell lines, and remains responsive to ligand-induced activation. This evidence concerns the gene IL7 and acute lymphoblastic leukemia.